GGrantIndex
Sort

326,823 grants matching clinical trial

Cardiovascular Regenerative Medicine

$2,285,071
Douglas W Losordo · Northwestern University At Chicago · P01 · FY2011 · HL

Cancer Center Support Grant

$2,284,983
Mary C. Beckerle · University Of Utah · P30 · FY2017 · CA

New Approaches to Tissue Repair

$2,284,977
Vincent Falanga · Roger Williams Hospital · P20 · FY2012 · GM

Cancer Center Support Grant

$2,284,970
Cornelia M Ulrich · University Of Utah · P30 · FY2018 · CA

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,284,866
Gary W Hunninghake · University Of Iowa · UL1 · FY2008 · RR

Development and identification of magnetic resonance, electrophysiological, and fiber-optic imaging biomarkers of myofascial pain

$2,284,469
Song Hu · Washington University · R61 · FY2022 · AT

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$2,284,358
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

DNA Sequencing and FACS Core Facilities

$2,284,339
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Therapeutic Window for Acute Stroke Therapy (P50)

$2,284,302
Brett C Meyer · University Of California, San Diego · P50 · FY2011 · NS

Development of Therapeutics for Biodefense and Emerging Infectious Diseases

$2,284,288
Timothy Henkel · Venatorx Pharmaceuticals, Inc. · N01 · FY2022 · AI

Clinical trials to prevent Alzheimer's Disease in Down Syndrome

$2,284,142
Michael S Rafii · University Of Southern California · R33 · FY2024 · AG

Examining the Persistence of Neurocognitive Benefits of Exercise

$2,284,063
Kirk I Erickson · Adventhealth Orlando · R01 · FY2025 · AG

UCLA Los Angeles Brazil AIDS Consortium

$2,284,062
Yvonne J Bryson · University Of California Los Angeles · U01 · FY2008 · AI

Development of an interferon-alpha-veltuzumab conjugate for CD20-targeted therapy

$2,283,892
Edmund A Rossi · Immunomedics, Inc. · R44 · FY2011 · CA

Weill Cornell Medicine (WCM) SPORE in Prostate Cancer

$2,283,108
Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2018 · CA

The District of Columbia Clinical Trials Unit (DC CTU)

$2,283,095
Manya Magnus · George Washington University · UM1 · FY2021 · AI

Cancer Center Support Grant

$2,282,863
Richard A. Van Etten · University Of California-Irvine · P30 · FY2016 · CA

Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment

$2,282,833
Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2022 · CA

TARGETING OBESITY AND BLOOD PRESSURE IN URBAN YOUTH

$2,282,764
Elaine A Borawski · Case Western Reserve University · U01 · FY2012 · HL

Healthy Eating,Physical Activity, & Glycemic Control in Young Children with T1D

$2,282,670
Randi Streisand · Children'S Research Institute · DP3 · FY2014 · DK

Investigating and targeting apolipoprotein E4 in Down syndrome-associated Alzheimer's disease

$2,282,487
Noah Ray Johnson · University Of Colorado Denver · RF1 · FY2023 · AG

A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia

$2,282,414
David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2012 · HL

The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer

$2,281,895
Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

Auditory function, cognition, language and brain structure in Down Syndrome

$2,281,845
Ruth Y Litovsky · University Of Wisconsin-Madison · R01 · FY2022 · DC

Locomotor Experience Applied Post-Stroke (LEAPS)

$2,281,467
Pamela W. Duncan · Duke University · R01 · FY2009 · NS